Ductal carcinoma in situ (DCIS): The importance of patient-reported outcomes (PRO)
- PMID: 32747864
- PMCID: PMC7398451
- DOI: 10.1007/s12609-020-00363-2
Ductal carcinoma in situ (DCIS): The importance of patient-reported outcomes (PRO)
Abstract
Purpose: Patient reported outcomes (PROs) are an optimal method for assessing quality of life (QOL), including physical and psychosocial health. This review summarizes PROs frequently assessed in the setting of a DCIS diagnosis.
Recent findings: Health-related QOL has generally been found to be modestly affected in women with DCIS and similar to women with invasive breast cancer. Several studies reported a substantial negative impact on sexual health and body image, including some differences based on surgery type. Some patients experience pain after treatment, although many physical symptoms resolve. The prevalence of anxiety and depression varied based on assessment timing, with symptoms improving over time. Women with DCIS often overestimate the risks associated both with DCIS and invasive cancer.
Summary: PROs provide critical information regarding the experiences of women following a DCIS diagnosis. Continued inclusion of PROs in clinical trials is warranted, further informing treatment decisions and adequately preparing patients for what to expect following treatment.
Keywords: DCIS; physical well-being; psychosocial well-being; quality of life; risk perceptions.
Conflict of interest statement
Conflict of Interest Laura Dominici and Shoshana Rosenberg declare no conflicts of interest relevant to this manuscript.
Similar articles
-
Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.J Natl Cancer Inst. 2008 Feb 20;100(4):243-51. doi: 10.1093/jnci/djn010. Epub 2008 Feb 12. J Natl Cancer Inst. 2008. PMID: 18270338
-
Patient-reported outcomes in ductal carcinoma in situ: A systematic review.Eur J Cancer. 2017 Jan;71:95-108. doi: 10.1016/j.ejca.2016.09.035. Epub 2016 Dec 15. Eur J Cancer. 2017. PMID: 27987454 Review.
-
Comparing Two Treatment Approaches for Women with Ductal Carcinoma In Situ (DCIS) — The PORTAL Study [Internet].Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 Jul. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 Jul. PMID: 38781408 Free Books & Documents. Review.
-
What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions?Breast Cancer. 2017 Sep;24(5):720-729. doi: 10.1007/s12282-017-0765-0. Epub 2017 Feb 28. Breast Cancer. 2017. PMID: 28247220
-
Ductal Carcinoma In Situ - Quo Vadis?Chirurgia (Bucur). 2021 Dec;116(5 Suppl):S5-S6. Chirurgia (Bucur). 2021. PMID: 34967322 Review.
Cited by
-
Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases.Neoplasia. 2022 Jun;28:100791. doi: 10.1016/j.neo.2022.100791. Epub 2022 Apr 8. Neoplasia. 2022. PMID: 35405500 Free PMC article.
References
-
- American Cancer Society. Breast Cancer Facts & Figures 2019-2020. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-... Accessed April 1, 2020.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous